ADVFN - Advanced Financial Network.
HOME» NYSE » N » NVO Stock Price » NVO Stock News

Novo Nordisk a S Share News

 Novo-nordisk a/s (denmark) Stock Price
NVO Stock Price
 Novo-nordisk a/s (denmark) Stock Chart
NVO Stock Chart
 Novo-nordisk a/s (denmark) Stock News
NVO Stock News
 Novo-nordisk a/s (denmark) Company Information
NVO Company Information
 Novo-nordisk a/s (denmark) Stock Trades
NVO Stock Trades

Novo Nordisk May Perform Stock Split - Chief Financial Officer

COPENHAGEN -(Dow Jones)- Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) may perform a stock split in the next couple of years, the company's chief financial officer Jesper Brandgaard said Thursday. "We have done several stock splits over the years, when the price has risen to levels that we found too high. With a price of more than $100, it is something we will consider again," Brandgaard said, speaking after the company released its fourth-quarter results. Novo Nordisk, the world's largest maker of insulin, earlier Thursday reported that its net profit rose 19% on the year in the fourth quarter, to 4.69 billion Danish kroner ($829 million). The result was better than expected, helped by strong growth in sales of its GLP-1 diabetes drug Victoza and ultra-long acting insulin Levemir. -By Flemming Emil Hansen and Niclas Rolander, Dow Jones Newswires; +46-8-5451-3102; [email protected]

Stock News for Novo Nordisk a S (NVO)
01/11/201717:59:00Bernstein Litowitz Berger & Grossmann LLP Announces Securities...
01/10/201710:01:15Report of Foreign Issuer (6-k)
01/09/201708:10:33Report of Foreign Issuer (6-k)
01/06/201706:15:46Report of Foreign Issuer (6-k)
12/27/201608:03:19Report of Foreign Issuer (6-k)
12/22/201605:37:00Roche Says Hemophilia Drug Reduces Bleeding in Late-Stage Trial
12/19/201610:25:18Report of Foreign Issuer (6-k)
12/13/201609:00:00Eli Lilly Offers Discount for Insulin
12/12/201610:54:58Report of Foreign Issuer (6-k)
12/09/201609:31:16Emisphere Restructures Debt Agreements, Providing Greater Stability...
12/08/201606:24:00Correction to Novo Nordisk Pledges to Limit Price Increases in...
12/06/201615:40:00Novo Nordisk Pledges to Limit Price Increases in U.S. for Its...
12/06/201615:33:00Novo Nordisk Pledges to Limit Price Increases in U.S. for Its...
12/05/201610:19:46Report of Foreign Issuer (6-k)
12/05/201609:42:00Novo Nordisk Files for Regulatory Approval of Once-Weekly Semaglutide...
12/05/201608:34:00Report of Foreign Issuer (6-k)
11/30/201606:05:09Report of Foreign Issuer (6-k)
11/29/201619:52:00Novo's New Insulin Reduces Risk of Low Blood Sugar, Study Shows
11/29/201617:00:00Novo's New Insulin Reduces Risk of Low Blood Sugar, Study Shows
11/29/201616:51:00Novo's New Insulin Reduces Risk of Low Blood Sugar, Study Shows

Novo Nordisk a S and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations